Background and aims: The study aims to analyze of fatty acid (FA) composition of arteries and blood plasma in atherosclerosis.
Material and method: The blood plasma in patients with coronary atherosclerosis was studied, the blood from healthy volunteers was used as control. There were also analyzed arteries of patients with severe atherosclerotic lesions and arteries of people with significantly less atherosclerotic changes.
Results: The received data indicates that there is a rather active penetration of FA from blood plasma lipoproteins into intima of arteries. Penetration of FA from blood lipoproteins into the depth of atherosclerotic aorta and an atherosclerotic plaque appears to be small and does not effect on their fatty acid composition, which is similar to that of free FA of blood plasma. The evidence of the increased activity of desaturases and fatty acid synthases in atherosclerotic and intact arteries in patients with severe atherosclerotic vascular lesions was obtained. This increase in activity may be related by relatively low content of polyunsaturated linoleic acid in blood plasma in atherosclerosis.
Conclusions: The increased activity of desaturases and fatty acid synthases as well as arterial wall hypoxia must promote accumulation of lipids in vascular wall by increasing the synthesis and inhibition of FA oxidation including free FA coming from blood.
2. Guyton JR, Klemp KF. Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler Thromb 14(8): 1305-1314, 1994.
3. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. J Circulation 92(5): 1355-1374, 1995.
4. Ritskes-Hoitinga J, Beynen AC. Atherosclerosis in the rat. Artery 16(1): 25-50 (1988).
5. Osipenko AN, Marochkov AV. Blood plasma plasmalogens and fatty acids in multiple organ dysfunction syndrome. Critical Care and Shock 20(2): 40-45, 2017.
6. Osipenko AN. Change of plasmalogen content of red blood cells in myocardial hypoxia and acidosis. Acta Cardiologica 73(1): 61-68, 2018.
7. Glantz SA. Primer of Biostatistics. McGraw-Hill: New York, 1994.
8. Vance DE, Vance JE. Biochemistry of lipids, lipoproteins and membranes. 5th ed. Amsterdam: Elsevier, 2008.
9. Hellmuth C, Demmelmair H, Schmitt I, Peissner W, Blüher M, Koletzko B. Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PLoS One 8(10): 74927, 2013.
10. Frape DL, Williams NR, Carpenter KL, Freeman MA, Palmer CR, Fletcher RJ. Insulin response and changes in composition of non-esterified fatty acids in blood plasma of middle-aged men following isoenergetic fatty and carbohydrate breakfasts. Br J Nutr 84 (5): 737-745, 2000.
11. Kotronen A, Seppänen-Laakso T, Westerbacka J, et al. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity 18(5): 937-944, 2010.
12. Sumida T. Clinical and experimental study on fatty acid composition of bone marrow lipid in hematologic disorders. Acta Med Nagasaki 9(3): 222-241, 1965.
13. Andersson A, Nälsén C, Tengblad S, Vessby B. Fatty acid composition of skeletal muscle reflects dietary fat composition in humans. Am J Clin Nutr 76(6): 1222-1229, 2002.
14. Frattola L, Canal N, Andreoli VM, Maffei F, Tonon GC. Lipid changes in neurogenic muscular atrophies. Research in experimental medicine 164(3): 241-246, 1974.
15. Julien C, Berthiaume L, Hadj-Tahar A, et al. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int 48(5): 404-414, 2006.
16. Hamlat N, Forcheron F, Negazzi S, et al. Lipogenesis in arterial wall and vascular smooth muscular cells: regulation and abnormalities in insulin-resistance. Cardiovasc Diabetol 8: 64, 23 December 2009.
17. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. Clin Invest 58(1): 200-211, 1976.
18. Heistad DD, Armstrong ML, Marcus ML. Hyperemia of the aortic wall in atherosclerotic monkeys. Circ Res 48(5): 669-675, 1981.
19. Steinmetz A. Treatment of diabetic dyslipoproteinemia. Exp Clin Endocrinol Diabetes 111(5): 239-245, 2003.
20. Boden G. Obesity and free fatty acids (FFA). Endocrinol Metab Clin North Am 37(3): 635-646, 2008.
21. Ebbert JO, Jensen MD. Fat depots, free fatty acids, and dyslipidemia. Nutrients 5(2): 498-508, 2013.
22. Carlson LA, Levi L, Orö L. Plasma lipids and urinary excretion of catecholamines in man during experimentally induced emotional stress, and their modification by nicotinic acid. J Clin Invest 47(8): 1795-1805, 1968.
23. Yew Tan C, Virtue S, Murfitt S, et al. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance Sci. Rep. 5: 18366, 2015.
24. Chakravarty B, Gu Z, Chirala SS, Wakil SJ, Quiocho FA. Human fatty acid synthase: Structure and substrate selectivity of the thioesterase domain. J PNAS 101(44): 15567-15572, 2004.
25. Wakil SJ, Abu-Elheiga LA. Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50: 138-143, 2009.
26. Browne CD, Hindmarsh EJ, Smith JW. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. J FASEB 20(12): 2027-2035, 2006.
27. Kusakabe T, Maeda M, Hoshi N, et al. Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem 48(5): 613-622, 2000.
28. Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 32(16): 1977-1985, 2011.
29. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8(11): 1249-1256, 2002.
30. Ntambi JM, Miyazaki M, Stoehr JP, et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA 99(17): 11482-11486 (2002).
31. Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 24: 345-376, 2004.
32. Kersten S. Effects of fatty acids on gene expression: role of peroxisome proliferator-activated receptor α, liver X receptor α and sterol regulatory element-binding protein-1c. Proceedings of the Nutrition Society 61(3): 371-374, 2002.
33. Teng Z, He J, Degnan AJ, et al. Critical mechanical conditions around neovessels in carotid atherosclerotic plaque may promote intraplaque hemorrhage. Atherosclerosis 223(2): 321-326, 2012.
34. Saini-Chohan HK, Mitchell RW, Vaz FM, Zelinski T, Hatch GM. Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases. J Lipid Res 53(1): 4-27, 2012.